SK pharmteco Posters

1. Adapting rcLVV Assays For Commercial Manufacturing 7/22/2025

   Witness a validated dual-assay approach for sensitive, CGMP-compliant detection of replication-competent lentiviruses, enhancing safety and regulatory confidence in lentiviral vector manufacturing.

2. Adapting A rcAAV Assay For Commercial Manufacturing 5/15/2025

   Witness how to implement sensitive, cell-based qPCR assays to reliably detect rcAAVs and safeguard the integrity of your rAAV gene therapy manufacturing process.

3. Control Strategies And Method Development For Nitrosamines In Peptide APIs And Drug Products 11/26/2024

   Pharmaceutical scientists and engineers must advance robust, sensitive, and efficient nitrosamine detection and control methods to ensure regulatory compliance and safeguard public health in peptide-based drugs.

4. cGMP-Ready Clonal HEK293 Cell Line For AAV, Lenti-, And Adenoviral Vectors 11/7/2024

   See how this advanced SKPT-HEK293 4G9 was able to provide a robust, CGMP-ready solution for efficient viral vector production, supporting a range of AAV serotypes and CAR-T Lenti-viral vectors for scalable manufacturing.

5. Development Of A Universal, GMP-Ready, Clonal HEK293 Cell Line 9/16/2024

   When manufacturing adeno-associated virus, lenti- and adenoviral vectors, see how this HEK293 cell line is optimized for suspension culture and viral vector production, which can significantly reduce costs.